Health & WellnessTech
CorneaCare, Inc.
D2C dry eye solution steamlining diagnosis, treatment, compliance and education
Philadelphia,
PA
Investment type:
Equity
(SAFE)
Target raise:
$50,000
- $150,000
Minimum investment:
$100
$100
End date:
May 01, 2022
May 01, 2022
ended
Share
Highlights
- Dry eye disease afflicts 30m+ US adults; aging population, increased screen time, contact lens use
- With 1.0% market capture (300,000 patients), CorneaCare could generate $126M of revenue per annum (not guaranteed)
- Our eCommerce portal provides convenient and effective treatment packages delivered monthly.
- Our digital therapeutic app promotes treatment compliance, monitoring, and collaborative care.
Our Story
We help consumers with dry eyes take control of their treatment.
Our Ambition
We want to be expanding from dry eye disease into other eye care markets